Dr. Vesselin Tomov
Co- Principal Investigator: Vesselin Tomov, MD, PhD
Dr. Tomov graduated from Harvard Medical School and completed his residency and fellowship training at the Hospital of the University of Pennsylvania. He is board certified in GI and specializes in the diagnosis and management of inflammatory bowel disease (IBD). Dr. Tomov conducts basic research in the area of mucosal immunology, particularly as it pertains to the pathogenesis of IBD. His current project is focused on T cell immune response to norovirus infection. Noroviruses are the leading cause of gastroenteritis globally and cause millions of acute and chronic infections each year. Currently there is no effective vaccine against noroviruses; furthermore, the potential contribution of noroviruses (and other viral pathogens) to intestinal inflammation in IBD remains unclear. Dr. Tomov’s research is aimed at addressing these two issues through basic science experiments in animal models, as well as translational work involving biopsies from IBD patients.